Barclays Maintains an 'Overweight' on Dun & Bradstreet (DNB); 3Q11 Post Call: 'Great Investment Opportunity,' $500M Buyback
Get Alerts DNB Hot Sheet
Price: $9.22 +0.88%
Rating Summary:
10 Buy, 8 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 16 | Down: 14 | New: 16
Rating Summary:
10 Buy, 8 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 16 | Down: 14 | New: 16
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Dun & Bradstreet (NYSE: DNB) price target of $80.00.
Barclays analyst says, "3Q'11 Beat Aided by Top-Line Acceleration: Core revenues grew +8% y/y to $439M, an acceleration Q2's +5%. N.A. grew +2% vs. +1% in 2Q (all organic; Optimizer ~20%). International grew organically +5%, driven by China and better performance in Europe. Margin improvements continued due to ongoing financial flexibility initiatives. Operating Income of $119M (+14%) beat our/Streets' $110M/$106M (margins were up 100bps y/y); and Adjusted EPS of $1.42 (+17% y/y) beat our/Streets' $1.33/$1.35." (Barclays raises FY11 EPS estimate from $6.03 to $6.15 and FY12 from $6.30 to $6.45)
For more ratings news on Dun & Bradstreet click here and for the rating history of Dun & Bradstreet click here.
Shares of Dun & Bradstreet closed at $68.02 yesterday.
Barclays analyst says, "3Q'11 Beat Aided by Top-Line Acceleration: Core revenues grew +8% y/y to $439M, an acceleration Q2's +5%. N.A. grew +2% vs. +1% in 2Q (all organic; Optimizer ~20%). International grew organically +5%, driven by China and better performance in Europe. Margin improvements continued due to ongoing financial flexibility initiatives. Operating Income of $119M (+14%) beat our/Streets' $110M/$106M (margins were up 100bps y/y); and Adjusted EPS of $1.42 (+17% y/y) beat our/Streets' $1.33/$1.35." (Barclays raises FY11 EPS estimate from $6.03 to $6.15 and FY12 from $6.30 to $6.45)
For more ratings news on Dun & Bradstreet click here and for the rating history of Dun & Bradstreet click here.
Shares of Dun & Bradstreet closed at $68.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cleveland Research Upgrades Dynatrace Inc. (DT) to Buy, 'optimism underlying fundamentals are likely to support upside'
- HSBC Upgrades Johnson & Johnson (JNJ) to Buy, 'Steady outlook, low expectations'
- 23andMe (ME) being taken private is the new most likely outcome - Analyst
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!